Akazawa S, Metzger B E, Freinkel N
J Clin Endocrinol Metab. 1986 May;62(5):984-9. doi: 10.1210/jcem-62-5-984.
Enzymatic assays were modified to permit sensitive and highly reproducible simultaneous measurements of D-mannose and D-glucose in biological fluids during weeks 34-40 of human pregnancy. Plasma mannose and glucose averaged 9.8 +/- 0.4 (+/- SEM) and 790 +/- 16 micrograms/ml, respectively, after an overnight fast in pregnant women (n = 22) with normal carbohydrate metabolism. Significantly higher plasma mannose levels were found, despite only minor increases in plasma glucose, in pregnant women with relatively well controlled diabetes mellitus after an overnight fast (16.9 +/- 0.6 micrograms/ml mannose; 883 +/- 29 micrograms/ml glucose; n = 31) or 3-4 h after breakfast (15.7 +/- 1.2 micrograms/ml mannose; 1159 +/- 101 micrograms/ml glucose; n = 19). Plasma mannose correlated significantly with plasma glucose in the women with diabetes mellitus, particularly after an overnight fast. Samples of amniotic fluid were also obtained from the gravida with diabetes mellitus to provide some index of simultaneous relationships in utero. Amniotic fluid mannose and glucose averaged 5.9 +/- 0.4 and 302 +/- 24 micrograms/ml, respectively, after an overnight fast and 6.7 +/- 1.3 and 459 +/- 84 micrograms/ml 3-4 h after breakfast. In amniotic fluid, as in plasma, the concurrent levels of mannose and glucose conformed to relatively fixed relationships. Thus, both fetus and mother appear to be exposed to readily demonstrable amounts of mannose during late gestation and the absolute as well as relative abundance of mannose may be increased coincident with faulty maternal glucoregulation. However, since mannose did not exceed 3% of the concurrent concentration of glucose in any instance, it does not seem likely that endogenous levels of circulating mannose can modify glucose utilization appreciably by competing with glucose for phosphorylation via hexokinase and subsequent intracellular processing.
对酶法分析进行了改进,以便在人类妊娠第34至40周期间对生物体液中的D-甘露糖和D-葡萄糖进行灵敏且高度可重复的同时测量。在碳水化合物代谢正常的孕妇(n = 22)中,禁食过夜后,血浆甘露糖和葡萄糖的平均水平分别为9.8±0.4(±SEM)和790±16微克/毫升。在禁食过夜后(甘露糖16.9±0.6微克/毫升;葡萄糖883±29微克/毫升;n = 31)或早餐后3 - 4小时(甘露糖15.7±1.2微克/毫升;葡萄糖1159±101微克/毫升;n = 19),患有相对控制良好的糖尿病的孕妇血浆甘露糖水平显著升高,尽管血浆葡萄糖仅略有升高。在患有糖尿病的女性中,血浆甘露糖与血浆葡萄糖显著相关,尤其是在禁食过夜后。还从患有糖尿病的孕妇获取羊水样本,以提供子宫内同时关系的一些指标。禁食过夜后,羊水甘露糖和葡萄糖的平均水平分别为5.9±0.4和302±24微克/毫升,早餐后3 - 4小时分别为6.7±1.3和459±84微克/毫升。与血浆一样,羊水中甘露糖和葡萄糖的同时水平符合相对固定的关系。因此,在妊娠后期,胎儿和母亲似乎都暴露于易于检测到的量的甘露糖中,并且甘露糖的绝对和相对丰度可能会随着母体葡萄糖调节异常而增加。然而,由于在任何情况下甘露糖都不超过同时期葡萄糖浓度的3%,循环中的内源性甘露糖水平似乎不太可能通过与葡萄糖竞争己糖激酶磷酸化及随后的细胞内加工而显著改变葡萄糖利用。